Novel pathogenic variant of MYBPC3 responsible for hypertrophic cardiomyopathy

Xiaofei Yang1,2, Zhenghao Li1, Qingfa Wang1

  • 1Department of Pediatrics, Yidu Central Hospital of Weifang, Weifang, Shandong, China.

Insights

A novel MYBPC3 gene variant (p.E911X) causes diverse hypertrophic cardiomyopathy phenotypes. Whole-exome sequencing aids in early screening and diagnosis of this genetic heart condition.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary genetic heart muscle disease.
  • Identifying pathogenic gene variants is crucial for understanding disease mechanisms and inheritance patterns.

Purpose of the Study:

  • To identify the pathogenic gene variant in a family with hypertrophic cardiomyopathy using whole-exome sequencing.
  • To correlate the identified gene variant with the clinical phenotypes observed in family members.

Main Methods:

  • Whole-exome sequencing (WES) was performed on DNA from a family affected by HCM.
  • Sanger sequencing confirmed the identified variant.
  • Bioinformatics tools predicted the functional impact of the variant.
  • Clinical data from family members were analyzed.

Main Results:

  • A novel heterozygous nonsense variant, MYBPC3:c.2731G > T (p.E911X), was identified in the proband.
  • The variant affects conserved amino acids and alters the MYBPC3 protein structure, including domain incompleteness and deletions.
  • Clinical data revealed diverse phenotypes among variant carriers, indicating functional protein damage.

Conclusions:

  • The novel MYBPC3 variant (p.E911X) leads to variable severity and clinical manifestations of hypertrophic cardiomyopathy.
  • Whole-exome sequencing is effective for comprehensive screening of HCM-associated genes, supporting early diagnosis and treatment strategies, particularly in children.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
107
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
166
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
107
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
136
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
364
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
115